Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Change in Cash (2016 - 2025)

Macrogenics (MGNX) has disclosed Change in Cash for 14 consecutive years, with -$22.9 million as the latest value for Q4 2025.

  • Quarterly Change in Cash fell 812.66% to -$22.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$125.6 million through Dec 2025, down 253.42% year-over-year, with the annual reading at -$125.6 million for FY2025, 253.42% down from the prior year.
  • Change in Cash for Q4 2025 was -$22.9 million at Macrogenics, up from -$50.6 million in the prior quarter.
  • The five-year high for Change in Cash was $115.4 million in Q1 2023, with the low at -$115.5 million in Q2 2023.
  • Average Change in Cash over 5 years is -$6.2 million, with a median of -$16.9 million recorded in 2023.
  • The sharpest move saw Change in Cash soared 3905.38% in 2022, then plummeted 812.66% in 2025.
  • Over 5 years, Change in Cash stood at -$67.1 million in 2021, then surged by 137.12% to $24.9 million in 2022, then tumbled by 55.57% to $11.1 million in 2023, then tumbled by 70.93% to $3.2 million in 2024, then tumbled by 812.66% to -$22.9 million in 2025.
  • According to Business Quant data, Change in Cash over the past three periods came in at -$22.9 million, -$50.6 million, and -$14.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.